June 15 -16, 2021 | VIRTUAL EVENT

Equipping pharma companies of all sizes with practical answers to problems that they actually have. Gain firsthand knowledge from peers who will share relevant case studies, successes and watchouts.

We’ve all experienced the impact of Covid on society and across many industries. While digital health has gained immense traction during this unfortunate time, that might mask the reality that the health system has been in steady decline across the value chain of stakeholders. The human impact needs to be carefully considered to determine how digital health can help reshape the commercial business model for pharma while unlocking new value for patients.

Life sciences commercialization is at a crucial inflection point. The promotional decline and organizational shifts need to be carefully addressed and unpacked. Major technological advances in digital health are occurring as industry realizes that leveraging digital health as a tool for improving patient outcomes and also a driver of commercial growth is not just a ‘nice to have’ but a ‘need to have’ to sustain relevance.

Join us at this inaugural event, a unique conference focused on connecting real-world solutions to real-world challenges. Come away with an actionable understanding of how pharma can be the bridge across an ailing healthcare system, a growing array of digital health solutions, and patients who are otherwise left to their own devices.

Together, let’s decode digital health.

CONFERENCE CO-CHAIRS

Conference Co-ChairPaul Ivans
Conference Co-Chair
Paul Ivans
Founder and CEO

EVOLUTION ROAD

Conference Co-ChairTodd Kolm
Conference Co-Chair
Todd Kolm
Practice Leader, Digital Health and Innovation

EVOLUTION ROAD

Conference Co-ChairPaul Ivans
Conference Co-Chair
Paul Ivans
Founder and CEO

EVOLUTION ROAD

Conference Co-ChairTodd Kolm
Conference Co-Chair
Todd Kolm
Practice Leader, Digital Health and Innovation

EVOLUTION ROAD

SPEAKER HIGHLIGHTS

Rohit Bansal
Rohit Bansal
US Commercial Lead – Digital Therapeutics

OTSUKA PHARMACEUTICALS

Larry Brooks
Larry Brooks
Global Alliances Manager – HCLS

Amazon Web Services

Aya Caldwell
Aya Caldwell
Executive Director Digital Products, Novartis Group Digital Office

NOVARTIS

George Cusatis
George Cusatis
Director, Device and Digital Health

MERCK

Sharon DeBacco
Sharon DeBacco
Vice President, Product Promotion and Communication

IRONWOOD PHARMACEUTICALS

Melinda Decker
Melinda Decker
Chief Commercial Officer

MYMEE

Chris DiCostanzo
Chris DiCostanzo
Vice President Patient Engagement

OPTIMIZERX

Shwen Gwee
Shwen Gwee
Vice President and Head of Global Digital Strategy

BRISTOL MYERS SQUIBB

Mimi Huizinga
Mimi Huizinga
Vice President and Head US Oncology Medical

NOVARTIS

Hans Kaspersetz
Hans Kaspersetz
CEO

ARTERIC

Conrod Kelly
Conrod Kelly
Executive Director, Global Health Equity, US Marketing

MERCK

Shameer Khader
Shameer Khader
Senior Director (Data Science, AI/ML, Digital Health & Bioinformatics)

ASTRAZENECA

Monique Levy
Monique Levy
Chief Commercial and Strategy Officer

WOEBOT HEALTH

Lauren Li
Lauren Li
Head of Digital Health

IPSEN

Alvaro Luna
Alvaro Luna
Associate Principal

EVOLUTION ROAD

Bryan Mallitz
Bryan Mallitz
Executive Director, Digital Health Alliances, US Market

MERCK

Kate Miller
Kate Miller
Principal, Practice Lead Digital Innovation

EVOLUTION ROAD

Mark Milton-Edwards
Mark Milton-Edwards
Head of Health Solutions, Digital Health

TEVA PHARMACEUTICALS

Lisa Podhayny
Lisa Podhayny
Director, Marketing, PR and Corporate Communications

BIODELIVERY SCIENCES INTERNATIONAL

Joe Powers
Joe Powers
Chief Digital Business Officer

OTSUKA PHARMACEUTICALS

Sai Rangarao
Sai Rangarao
Vice President and Head of Marketing

BIODELIVERY SCIENCES INTERNATIONAL

Stephen Ranjan
Stephen Ranjan
Vice President, Franchise Lead Professional and Non-Insulin Therapy Solutions, Strategy and Customer Solutions

ROCHE DIABETES CARE

Brenda Raphael
Brenda Raphael
Former Vice President, New Products and Launch Excellence

NOVARTIS

Meghan Rivera
Meghan Rivera
Chief Marketing Officer and Head of Commercial

AKILI INTERACTIVE

Christine Sakdalan
Christine Sakdalan
Head of Franchise Strategy and Customer Solutions

JANSSEN

Alexia Burnett Salinas
Alexia Burnett Salinas
Group Product Director, Customer Solutions, Neuroscience

JOHNSON & JOHNSON

Rachel Sha
Rachel Sha
Vice President, Digital Strategy and Governance

SANOFI

Ryan Sysko
Ryan Sysko
CEO

AMALGAM RX

Josie Waters
Josie Waters
Senior Director, Consumer Marketing

IRONWOOD PHARMACEUTICALS

Amy West
Amy West
Head of US Digital Health and Innovation Strategy

NOVO NORDISK

Kate Wolin
Kate Wolin
Co-Founder

COEUS

Francesca Wuttke
Francesca Wuttke
Chief Digital Officer

ALMIRALL

Jian Yang
Jian Yang
Senior Director, Digital Health

ELI LILLY

Top 5 Reasons to Attend

Reason 1 Why Digital Health is a ‘Need to Have’ and Not a ‘Nice to Have’ for Life Science Commercial Teams Now

  • Addressing the key healthcare dynamics that are changing the life science commercial landscape
  • Detailing how life science leaders expect to evolve their their current commercial models over the near and long -term horizons

Reason 2 Reviewing Pharma Organizational Dynamics for Digital Health:

  • Organizing principles – centralized COEs vs decentralized model decision making process
  • Evaluate the partnership model
  • Create adaptive mindset – business impact for innovation and taking the long view
  • Change management

Reason 3 Evaluating How the Life Sciences Customer Value Proposition is Changing and How Digital Health addresses these Dynamics

  • Payers
  • Patient
  • HCP
  • Pharmacy/Specialty Pharmacy
  • Social Determinants of Health (SDoH)

Reason 4 Profiling the Rapidly Expanding Solution Areas Across the Digital Health Landscape

  • Key Digital Health solution areas such as telehealth, digital biomarkers, digital care plans, etc.
  • Precision health
  • Rise of prescription digital therapeutics
  • End to end platforms
  • Hospitals @ home
  • Role of pharma in Digital Health solutions

Reason 5 Deep Dive Analysis on the Largest Needs and Biggest Opportunities in Digital Health Across Disease States and Conditions

  • Oncology
  • Primary Care
  • Mental Health
  • Specialty
  • Med Device

WHO SHOULD ATTEND

SVPs, VPs, Directors, Heads, and Managers from the pharmaceutical, biotechnology, and medical device industries whose responsibilities include: Brand Marketing, Digital Innovation, Commercial Model Innovation, Digital Health (i.e, digital therapeutics, telemedicine, big data/ advanced analytics, connected health and wearables, digital biomarkers, digital care plans, etc.)

  • Digital Health
  • Digital Innovation
  • Digital Medicine
  • Digital Accelerator
  • Digital Marketing
  • Digital Strategy
  • Digital Business Development/ Solutions
  • Commercial Excellence/ Operations
  • Commercial Strategy
  • Patient Solutions
  • Patient Engagement
  • Innovation
  • External Innovation
  • BD and In-Licensing
  • Clinical Innovation
  • Clinical Operations
  • HEOR
  • Brand Management
  • Product Management
  • R&D Communications
  • Medical Affairs
  • Legal Counsel and MLR
  • Compliance

Strategic Partner

PARTNERS

MEDIA PARTNERS

NETWORKING CAPABILITIES

✔ Virtual Matchmaking: Visit our virtual lobby and connect with fellow attendees using our platform’s matchmaking technology. You can chat, video, and even make a list of the people you want to meet and the knowledge you’re looking to gain through our bespoke 1:1 match-making services

✔ Roundtable Networking throughout the Summit will give you the chance to connect and meet in-depth your fellow attendees as well as our Sponsors and Speakers

✔ The platform we use allows us to make polls, QA, and chat during the sessions.

✔ Virtual Happy Hour: Grab a drink and bring it to your screen to cheers from afar while continuing to chat with and get to know your fellow conference participants.

Pharmaceutical Companies

Solution/Technology Provider:

GROUP DISCOUNTS AVAILABLE!

Contact Gabby Robles at gabby@momentumevents.com to get more information.

Click here to view the cancellation/refund/transfer policy